Qiagen N.V. Quarterly Balance Sheet
NYSE: QGENHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Qiagen N.V. financial position
As of Dec 31, 2025, Qiagen N.V. reported total assets of $6.28 billion, up 2.2% from a year earlier against total liabilities of $2.50 billion. Shareholders' equity stood at $3.78 billion, or 60.1% of assets. The company held $839.0 million in cash and equivalents against $1.65 billion of debt, a net debt position of $815.4 million.
The current ratio (current assets divided by current liabilities) was 3.90, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.44.
Summary generated from market data by MetaCap's automated system. Methodology
Qiagen N.V. balance sheet (quarterly)
| Quarter (USD) | Q4 20252025-12-31 | Q4 20242024-12-31 | Q4 20232023-12-31 | Q4 20222022-12-31 | Q4 20212021-12-31 | Q4 20202020-12-31 | Q4 20192019-12-31 | Q4 20182018-12-31 | Q4 20172017-12-31 | Q4 20162016-12-31 | Q4 20152015-12-31 | Q4 20142014-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 839.00M | 663.55M | 668.08M | 730.67M | 880.52M | 597.98M | 623.65M | 1.16B | 657.71M | 439.18M | 290.01M | 392.67M |
| Short-Term Investments | 259.91M | 489.44M | 389.70M | 687.60M | 184.78M | 117.25M | 129.59M | 234.61M | 359.20M | 93.00M | 130.82M | 184.04M |
| Receivables | 402.61M | 349.28M | 381.88M | 323.75M | 362.13M | 380.52M | 385.12M | 351.61M | 329.14M | 278.24M | 273.85M | 265.23M |
| Inventory | 301.89M | 279.26M | 398.38M | 357.96M | 327.52M | 291.18M | 170.70M | 162.91M | 155.93M | 136.55M | 136.59M | 132.28M |
| Total Current Assets | 2.00B | 1.96B | 2.15B | 2.39B | 2.11B | 1.62B | 1.57B | 2.16B | 1.65B | 1.04B | 961.40M | 1.15B |
| Property, Plant & Equipment | 923.95M | 753.61M | 765.04M | 662.17M | 638.18M | 559.37M | 455.24M | 511.66M | 494.32M | 436.65M | 442.94M | 428.09M |
| Goodwill | 2.70B | 2.43B | 2.48B | 2.35B | 2.35B | 2.36B | 2.14B | 2.11B | 2.01B | 1.93B | 1.88B | 1.89B |
| Intangible Assets | 386.43M | 303.81M | 526.82M | 544.80M | 627.44M | 726.19M | 632.43M | 475.04M | 499.32M | 557.16M | 636.42M | 726.91M |
| Total Assets | 6.28B | 5.69B | 6.12B | 6.29B | 6.15B | 5.87B | 5.24B | 5.75B | 5.04B | 4.31B | 4.18B | 4.45B |
| Accounts Payable | 72.66M | 83.27M | 84.16M | 98.73M | 101.22M | 118.15M | 84.77M | 69.42M | 59.20M | 51.22M | 52.31M | 46.12M |
| Short-Term Debt | 0 | 551.88M | 587.97M | 389.55M | 847.63M | 42.54M | 285.24M | 503.12M | 0 | — | 0 | 131.12M |
| Total Current Liabilities | 512.14M | 1.04B | 1.08B | 974.52M | 1.52B | 572.17M | 951.35M | 972.19M | 324.79M | 308.43M | 268.35M | 431.63M |
| Long-Term Debt | 1.65B | 839.66M | 921.82M | 1.47B | 1.09B | 1.88B | 1.42B | 1.67B | 1.76B | 1.07B | 1.05B | 1.04B |
| Total Liabilities | 2.50B | 2.12B | 2.31B | 2.82B | 3.05B | 3.07B | 2.70B | 3.11B | 2.50B | 1.70B | 1.61B | 1.79B |
| Shareholders' Equity | 3.78B | 3.57B | 3.81B | 3.47B | 3.10B | 2.80B | 2.54B | 2.63B | 2.54B | 2.61B | 2.57B | 2.65B |
| Retained Earnings | 2.75B | 2.45B | 2.46B | 2.16B | 1.79B | 1.32B | 1.18B | 1.38B | 1.25B | 1.26B | 1.21B | 1.13B |
| Total Debt | 1.65B | 1.39B | 1.51B | 1.86B | 1.94B | 1.92B | 1.71B | 2.17B | 1.76B | 1.07B | 1.05B | 1.17B |
| Net Cash (Debt) | -555.51M | -238.56M | -452.01M | -443.18M | -876.47M | -1.21B | -953.12M | -780.52M | -741.35M | -534.92M | -628.20M | -595.38M |
This table shows 12 quarterly periods of Qiagen N.V.'s balance sheet, from Q4 2025 back to Q4 2014, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow QGEN's reporting calendar. What is a balance sheet?